Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021
Authors:
- Richard A. TeranRTRichard A. Teran
- Kelly A. WalblayKWKelly A. Walblay
- Elizabeth L. ShaneESElizabeth L. Shane
- Shannon XydisSXShannon Xydis
- Stephanie GretschSGStephanie Gretsch
- Alexandra GagnerAGAlexandra Gagner
- Usha SamalaUSUsha Samala
- Hyeree ChoiHCHyeree Choi
- Christy ZelinskiCZChristy Zelinski
- Stephanie R. BlackSBStephanie R. Black
Open Access
- 30 April 2021
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 70 (17) , 632-638
Abstract
Twenty-two possible breakthrough SARS-CoV-2 infections occurred among fully vaccinated persons ≥14 days after their second dose of COVID-19 vaccine. Two thirds of persons were asymptomatic. A minority of persons with breakthrough infection experienced mild to moderate COVID-19–like symptoms; two COVID-19–related hospitalizations and one death occurred. No facility-associated secondary transmission was identified.Keywords
This publication has 8 references indexed in Scilit:
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program — United States, December 2020–January 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Rates of COVID-19 Among Residents and Staff Members in Nursing Homes — United States, May 25–November 22, 2020MMWR. Morbidity and Mortality Weekly Report, 2021
- Intermittent viral shedding in respiratory samples of patients with SARS-CoV-2: observational analysis with infection control implicationsJournal of Hospital Infection, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020MMWR. Morbidity and Mortality Weekly Report, 2020